
A once-nightly drop already used to reverse pupil dilation gains a near-vision indication.
Lifitegrast ophthalmic solution (Xiidra) 5% is indicated for the treatment of the signs and symptoms of dry eye disease.
Medication Pearl of the Day: Lifitegrast Ophthalmic Solution (Xiidra)
Indication: Lifitegrast ophthalmic solution (Xiidra) 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED).
Insight:
Sources:





